Jeffrey S. Nye

Affiliations: 
Molecular Pharmacology and Biological Chemistry Northwestern University, Evanston, IL 
Google:
"Jeffrey Nye"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Prins ND, van der Flier WA, Knol DL, et al. (2014) The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial. Alzheimer's Research & Therapy. 6: 47
Feldman HH, Haas M, Gandy S, et al. (2014) Alzheimer's disease research and development: a call for a new research roadmap. Annals of the New York Academy of Sciences. 1313: 1-16
Hager K, Baseman AS, Nye JS, et al. (2014) Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease. Neuropsychiatric Disease and Treatment. 10: 391-401
Di Prospero NA, Gambale JJ, Pandina G, et al. (2014) Evaluation of JNJ-26489112 in patients with photosensitive epilepsy: a placebo-controlled, exploratory study. Epilepsy Research. 108: 709-16
Tobe BT, Brandel MG, Nye JS, et al. (2013) Implications and limitations of cellular reprogramming for psychiatric drug development. Experimental & Molecular Medicine. 45: e59
Tobe BT, Snyder EY, Nye JS. (2011) Modeling complex neuropsychiatric disorders with human induced pluripotent stem cells. Current Opinion in Pharmacology. 11: 521-7
Carter DB, Dunn E, Pauley AM, et al. (2008) Changes in gamma-secretase activity and specificity caused by the introduction of consensus aspartyl protease active motif in Presenilin 1. Molecular Neurodegeneration. 3: 6
Winblad B, Gauthier S, Scinto L, et al. (2008) Safety and efficacy of galantamine in subjects with mild cognitive impairment. Neurology. 70: 2024-35
Yao C, Raoufinia A, Gold M, et al. (2005) Steady-state pharmacokinetics of galantamine are not affected by addition of memantine in healthy subjects. Journal of Clinical Pharmacology. 45: 519-28
Sebold CD, Melvin EC, Siegel D, et al. (2005) Recurrence risks for neural tube defects in siblings of patients with lipomyelomeningocele Genetics in Medicine. 7: 64-67
See more...